FDA Clears AISAP CARDIO: AI-Powered Ultrasound Revolutionizes Point-of-Care Diagnostics August 26, 2024
ReAlta Life Sciences Appoints David Marek as CEO and Paolo Martini, Ph.D., as Chief R&D Officer August 26, 2024
Retension Pharmaceuticals Secures $10.4M Series A to Advance Phase 2 Hypertension Study August 25, 2024
